Publications

https://www.ncbi.nlm.nih.gov/pubmed/?term=Fleckenstein+AE

• Baladi MG, Nielsen SM, McIntosh JM, Hanson GR, Fleckenstein AE (2016). Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors. Behav Pharmacol, 27(5), 422-30.
• Baladi MG, Newman AH, Nielsen SM, Hanson GR, Fleckenstein AE (2014). Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia. Eur J Pharmacol, 732, 105-10.
• Baladi MG, Nielsen SM, Umpierre A, Hanson GR, Fleckenstein AE (2014). Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats. Behav Pharmacol, 25(8), 758-65.
• Curtin K, Fleckenstein AE, Keeshin BR, Yurgelun-Todd DA, Renshaw PF, Smith KR, Hanson GR (2018). Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder. Neuropsychopharmacology, 43(13), 2548-2555.
• Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR (2015). Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment. Drug Alcohol Depend, 146, 30-8.
• Fricks-Gleason AN, German CL, Hoonakker AJ, Friend DM, Ganesh KK, Carver AS, Hanson GR, Fleckenstein AE, Keefe KA (2016). An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity. Synapse, 70(4), 139-46.
• German CL, Gudheti MV, Fleckenstein AE, Jorgensen EM (2017). Brain Slice Staining and Preparation for Three-Dimensional Super-Resolution Microscopy. Methods Mol Biol, 1663, 153-162.
• German CL, Baladi MG, McFadden LM, Hanson GR, Fleckenstein AE (2015). Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacol Rev, 67(4), 1005-24.
• German CL, Alburges ME, Hoonakker AJ, Fleckenstein AE, Hanson GR (2014). Mephedrone alters basal ganglia and limbic dynorphin systems. Synapse, 68(12), 634-640.
• German CL, Hoonakker AH, Fleckenstein AE, Hanson GR (2014). Mephedrone alters basal ganglia and limbic neurotensin systems. J Neurochem, 130(3), 402-7.
• German CL, Fleckenstein AE, Hanson GR (2014). Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci, 97(1), 2-8.
• Hanson GR, Venturelli PJ, Fleckenstein AE (in preparation). Drugs and Society (14th Edition). Boston, MA: Jones and Bartlett.
• Hanson GR, Venturelli PJ, Fleckenstein AE (2018). Drugs and Society (13th Edition). Boston, MA: Jones and Bartlett.
• Hanson GR, Venturelli PJ, Fleckenstein AE (2015). Drugs and Society (12th Edition). Boston, MA: Jones and Bartlett.
• Hanson GR, Venturelli PJ, Fleckenstein AE (2012). Drugs and Society (11th Edition). Boston, MA: Jones and Bartlett.
• Hanson GR, Venturelli PJ, Fleckenstein AE (2008). Drugs and Society (10th Edition). Boston, MA: Jones and Bartlett.
• Hanson GR, Venturelli PJ, Fleckenstein AE (2004). Drugs and Society (8th Edition). Boston, MA: Jones and Bartlett.
• Hanson GR, Venturelli PJ, Fleckenstein AE (2002). Drugs and Society (7th Edition). Boston, MA: Jones and Bartlett.
• Hanson GR, Venturelli PJ, Fleckenstein AE, contributing author (2000). Drugs and Society (6th Edition). Boston, MA: Jones and Bartlett.
• McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE (2015). Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology, 93, 146-54.
• McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE (2014). Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor. Int J Neuropsychopharmacol, 17(8), 1315-20.
• Pittenger ST, Swalve N, Chou S, Smith MD, Hoonakker AJ, Pudiak CM, Fleckenstein AE, Hanson GR, Bevins RA (2016). Sex differences in neurotensin and substance P following nicotine self-administration in rats. Synapse, 70(8), 336-46.
• Vieira-Brock PL, McFadden LM, Nielsen SM, Ellis JD, Walters ET, Stout KA, McIntosh JM, Wilkins DG, Hanson GR, Fleckenstein AE (2015). Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits. J Pharmacol Exp Ther, 355(3), 463-72.
• Vieira-Brock PL, McFadden LM, Nielsen SM, Smith MD, Hanson GR, Fleckenstein AE (2015). Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits. Int J Neuropsychopharmacol, 18(12).